NCT06018558 - Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

February 17, 2026

Study Completion Date

May 29, 2026

Conditions

Geographic Atrophy

Interventions

GENETIC

OCU410

Subretinal administration of OCU410

Trial Locations (12)

The University of Pittsburgh, Pittsburgh

Duke Eye Center, Durham

Advanced Research, LLC, Coral Springs

Mississippi Retina Associates, Jackson

Miidwest Eye Institute, Carmel

Gundersen Health System, La Crosse

The Retina Institute, St Louis

A) Retina Foundation of the Southwest, Dallas

B) Retina Consultants of Texas, Bellaire

Valley retina Institute, McAllen

Associated Retina Consultants, Phoenix

Mid Atlantic Retina, Cherry Hill